Form 4: Rapid Micro Biosystems CEO Sells Shares for Tax

Sentiment:

Insider Transaction Report


Rapid Micro Biosystems' President and CEO, Robert G. Spignesi Jr., sold 17,922 shares of Class A Common Stock to cover tax obligations.

Summary

  • Robert G. Spignesi Jr., President and CEO of Rapid Micro Biosystems, Inc. (RPID), reported a sale of company stock.
  • The transaction involved the disposition of 17,922 shares of Class A Common Stock.
  • The shares were sold at a price of $4.1115 per share.
  • The sale occurred on March 10, 2026.
  • This sale was an automatic transaction to cover tax obligations associated with the vesting of restricted stock units.
  • Following this transaction, Robert G. Spignesi Jr. beneficially owns 1,169,848 shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is a routine, non-discretionary transaction to cover tax liabilities from RSU vesting, rather than a discretionary sale based on market outlook.

Positives

  • The underlying event, the vesting of restricted stock units, represents compensation earned by the executive, which is a positive for the individual.

Negatives

  • The transaction resulted in a reduction of Robert G. Spignesi Jr.'s direct beneficial ownership by 17,922 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that tax-related sales of vested restricted stock units are a common and often routine occurrence for executives, not typically indicative of a change in company fundamentals or management's long-term outlook.

Stakeholder Impact

  • Minimal direct impact on shareholders as this is a routine, non-discretionary sale for tax purposes related to executive compensation.
  • Positive for the executive, Robert G. Spignesi Jr., as it represents the realization of compensation through vested restricted stock units.

Key Dates

DateDescription
03/10/2026Date of transaction (sale of Class A Common Stock)
03/12/2026Date the Form 4 was signed by the attorney-in-fact

Keywords

Rapid Micro Biosystems, RPID, Insider Trading, Form 4, Stock Sale, CEO, Director, Restricted Stock Units, Tax Obligations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.